Iris Lansdorp‐Vogelaar
Biographic Data
| ID | 7753532 |
|---|---|
| NAME | Iris Lansdorp‐Vogelaar |
| GIVEN NAMES | Iris |
| FAMILY NAME | Lansdorp‐Vogelaar |
| SIGNATURE | VOGELAAR I L |
| AFFILIATIONS | Erasmus MC |
| ORCID | 0000-0002-9438-2753 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2015 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Implementation of risk stratification within bowel cancer screening
From the perspective of public acceptability, risk stratification using current data could be implemented immediately, ahead of more complex strategies. Collecting additional data for lifestyle and/or genetic risk assessment was also considered acceptable but the practicalities of collecting such data and how the programme would be communicated require careful consideration
Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model
The Basque Country CRC Programme results are aligned to its strategy and comparable to other programmes. MISCAN model was found to be a useful tool to predict the benefits of the programme in the future. The effectiveness of the Programme has not been formally established as case control studies are required to determine long term benefits from the screening strategy
Cost-Savings to Medicare From Pre-Medicare Colorectal Cancer Screening
BACKGROUND: Many individuals have not received recommended colorectal cancer (CRC) screening before they become Medicare eligible at the age of 65. We aimed to estimate the long-term implications of increased CRC screening in the pre-Medicare population (50-64 y) on costs in the pre-Medicare and Medicare populations (65+ y). METHODS: We used 2 independently developed microsimulation models [Microsimulation Screening Analysis Colon (MISCAN) and Si…
No prominent works on this page.
Cost-Savings to Medicare From Pre-Medicare Colorectal Cancer Screening
BACKGROUND: Many individuals have not received recommended colorectal cancer (CRC) screening before they become Medicare eligible at the age of 65. We aimed to estimate the long-term implications of increased CRC screening in the pre-Medicare population (50-64 y) on costs in the pre-Medicare and Medicare populations (65+ y). METHODS: We used 2 independently developed microsimulation models [Microsimulation Screening Analysis Colon (MISCAN) and Si…
Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model
The Basque Country CRC Programme results are aligned to its strategy and comparable to other programmes. MISCAN model was found to be a useful tool to predict the benefits of the programme in the future. The effectiveness of the Programme has not been formally established as case control studies are required to determine long term benefits from the screening strategy
Implementation of risk stratification within bowel cancer screening
From the perspective of public acceptability, risk stratification using current data could be implemented immediately, ahead of more complex strategies. Collecting additional data for lifestyle and/or genetic risk assessment was also considered acceptable but the practicalities of collecting such data and how the programme would be communicated require careful consideration
Cancer (3 works) · Colonoscopy (3 works) · Colorectal cancer (3 works) · Colorectal Cancer Screening and Detection (3 works) · Environmental health (3 works) · Internal Medicine (3 works) · Medicine (3 works) · Population (3 works) · Biostatistics (2 works) · Colorectal cancer screening (2 works)